Clik here to view.
Schrödinger 宣布与赛诺菲合作提供计算机资源以支持后者的药物发现项目
纽约 (美国商业资讯)–Schrödinger, Inc.今天宣布与赛诺菲达成一项合作， Schrödinger 将为多达10个药物发现项目提供全方位的计算机药物设计支持，从靶点分析和验证到先导化合物认定和先导化合物优化。根据这份包含临床前里程碑收款、内容广泛的多年期合作协议的条款，Schrödinger有望收取多达1.2亿美元。...
View ArticleClik here to view.
Clik here to view.
TPGがアプタリス・ファーマシューティカル・テクノロジーズの買収を完了し、アプタリスの社名をAdare Pharmaceuticalsに変更
米ニュージャージー州ブリッジウォーター & テキサス州フォートワース （ビジネスワイヤ） — アプタリス・ファーマシューティカル・テクノロジーズは本日、Actavis plcよりグローバルプライベートエクイティ企業TPGに対する当社の売却が完了したと発表しました。また当社の新しい社名はAdare...
View ArticleClik here to view.
Cytori and Lorem Vascular Receive Regulatory Clearance in China
SAN DIEGO & BEIJING Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution® System by...
View ArticleClik here to view.
Regulatory Agencies in Asia and the U.S. Purchase Multiple Licenses of...
LANCASTER, Calif. Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that...
View ArticleClik here to view.
Medidata Expands Partnership with Peking University to Increase Access to...
NEW YORK Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the expansion of its partnership with Peking University...
View ArticleClik here to view.
Cytori 和 Lorem Vascular 获中国监管部门批准上市
圣迭戈和北京 (美国商业资讯) — Cytori Therapeutics, Inc. (NASDAQ: CYTX)今天宣布，中华人民共和国国家食品药品监督管理局(CFDA)已核准了该公司的Cytori Celution®系统，并向其独家授权人Lorem...
View ArticleClik here to view.
WaVe Life Sciences Appoints Roberto Guerciolini, M.D., as Senior Vice...
BOSTON & OKINAWA, Japan WaVe Life Sciences today announced that Roberto Guerciolini, M.D., has been appointed as Senior Vice President and Head of Early Development. He was most recently Vice...
View ArticleClik here to view.
Promega Nano-Glo® Dual-Luciferase® Reporter Assay Enables More Sensitive...
MADISON, Wis. Promega Corporation announces the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase technology,...
View ArticleClik here to view.
Dr. Reddy’s Laboratories and Its Subsidiary Promius PharmaTM Announce the...
HYDERABAD, India & Princeton, N.J. Dr. Reddy’s Laboratories (NYSE:RDY) and its subsidiary, Promius Pharma™, LLC today announced the filing of three 505(b)(2) New Drug Applications (NDAs) with...
View ArticleClik here to view.
Provectus Biopharmaceuticals to Present at 7th Annual International...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
PPD and SNBL Complete Joint Venture to Provide Japanese Clinical Development...
WILMINGTON, N.C. & TOKYO Pharmaceutical Product Development, LLC (PPD) and Shin Nippon Biomedical Laboratories Ltd. (SNBL) (TSE:2395) today announced the closing of an agreement to form a joint...
View ArticleClik here to view.
SanBio Announces Pricing of Initial Public Offering on Tokyo Stock Exchange
TOKYO & MOUNTAIN VIEW, Calif. SanBio, Co. Ltd. announced today the pricing of an initial public offering of 4,000,000 shares, or 8.6 percent of its common stock, at an offer price of 2,000...
View ArticleClik here to view.
社名変更に関するお知らせ（ストラテジア製薬）
ボストン （ビジネスワイヤ） — Boston Strategics Corp.（ボストン・ストラテジクス社、本社：米国マサチューセッツ州ボストン、代表取締役社長：古屋圭三）は、2015年4月７日付けで、Strategia Therapeutics, Inc. (ストラテジア製薬) へと社名を変更しましたので、お知らせいたします。 旧社名：Boston Strategics Corp....
View ArticleClik here to view.
IBA and Toshiba Sign Strategic Partnership in Particle Therapy
LOUVAIN-LA-NEUVE, Belgium & TOKYO IBA (Ion Beam Applications S.A.) and Toshiba Corporation (TOKYO:6502) today announce the signing of a global collaboration to expand access to advanced particle...
View ArticleClik here to view.
Health Purchasing Victoria Selects BravoSolution to Advance Sourcing and...
SYDNEY Health Purchasing Victoria, the collective purchasing organization for public health services and hospitals in Victoria, has partnered with BravoSolution to bolster its procurement...
View ArticleClik here to view.
PPD 与 SNBL完成合资企业的组建，提供日本临床开发服务和进一步合作
北卡罗莱纳州威尔明顿和东京 (美国商业资讯)–Pharmaceutical Product Development, LLC (PPD) 与新日本科学株式会社(SNBL) (TSE:2395)今天宣布，就在日本组建一家提供临床开发服务的合资企业的协议已全部完成。 此次交易完成后，PPD-SNBL成为日本最大的临床开发服务提供商之一，将同时服务于寻求开展全球性临床试验和仅在日本开展试验的客户。...
View ArticleClik here to view.
IBA与东芝签署粒子疗法战略伙伴关系
比利时LOUVAIN-LA-NEUVE和东京 (美国商业资讯) — IBA (Ion Beam Applications S.A.)与东芝公司(TOKYO:6502)今天宣布签署一份全球合作协议，以拓展世界各地的先进粒子疗法可及性。东芝医疗系统公司(Toshiba Medical Systems...
View ArticleClik here to view.
Replicor to Present at the 2015 Lancet Viral Hepatitis Conference
NEW YORK Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B (HBV) and hepatitis D (HDV) infection, today announced that it will present...
View ArticleClik here to view.
Replicorが2015年ランセット・ウイルス性肝炎会議で発表へ
ニューヨーク （ビジネスワイヤ） — 慢性B型肝炎（HBV）およびD型肝炎（HDV）に感染した患者向けの治療薬に絞った開発に取り組む非公開バイオ製薬企業のReplicor Inc.は本日、2015年4月10～12日に中国・上海で開催されるランセット・ウイルス性肝炎会議で、最新の臨床データを公表すると発表しました。データは、REP...
View Article